For example, targeting of PAD4 with GSK484 inhibitor repressed NETs formation and prevented dormant cancer cell awakening in a breast cancer model (110); targeting PAD4 with the novel PAD4 inhibitor BMS-P5, delayed the appearance of symptoms and MM progression (149). The gene discussed is PADI4; the disease is breast carcinoma.